The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia

被引:222
作者
Lee, JT [1 ]
McCubrey, JA
机构
[1] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA
[2] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Greenville, NC USA
关键词
Ras; Raf; MEK; ERK; phosphatase; transcription factor; inhibitors; IL-3; signal transduction; leukemia; oncogenes; PI3K; Akt;
D O I
10.1038/sj/leu/2402460
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Raf/MEK/ERK (MAPK) signal transduction cascade is a vital mediator of a number of cellular fates including growth, proliferation and survival, among others. The focus of this review centers on the MAPK signal transduction pathway, its mechanisms of activation, downstream mediators of signaling, and the transcription factors that ultimately alter gene expression. Furthermore, negative regulators of this cascade, including phosphatases, are discussed with an emphasis placed upon chemotherapeutic intervention at various points along the pathway. In addition, mounting evidence suggests that the PI3K/Akt pathway may play a role in the effects elicited via MAPK signaling; as such, potential interactions and their possible cellular ramifications are discussed.
引用
收藏
页码:486 / 507
页数:22
相关论文
共 372 条
  • [31] Identification of target genes of oncogenic transcription factors
    Boyd, KE
    Farnham, PJ
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (01): : 9 - 28
  • [32] The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44(MAPK) cascade
    Brondello, JM
    Brunet, A
    Pouyssegur, J
    McKenzie, FR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1368 - 1376
  • [33] Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
    Brunet, A
    Bonni, A
    Zigmond, MJ
    Lin, MZ
    Juo, P
    Hu, LS
    Anderson, MJ
    Arden, KC
    Blenis, J
    Greenberg, ME
    [J]. CELL, 1999, 96 (06) : 857 - 868
  • [34] THE ETS DOMAIN PROTEIN POINTED-P2 IS A TARGET OF MAP KINASE IN THE SEVENLESS SIGNAL-TRANSDUCTION PATHWAY
    BRUNNER, D
    DUCKER, K
    OELLERS, N
    HAFEN, E
    SCHOLZ, H
    KLAMBT, C
    [J]. NATURE, 1994, 370 (6488) : 386 - 389
  • [35] Buchdunger E, 1996, CANCER RES, V56, P100
  • [36] SELECTIVE-INHIBITION OF THE PLATELET-DERIVED GROWTH-FACTOR SIGNAL-TRANSDUCTION PATHWAY BY A PROTEIN-TYROSINE KINASE INHIBITOR OF THE 2-PHENYLAMINOPYRIMIDINE CLASS
    BUCHDUNGER, E
    ZIMMERMANN, J
    METT, H
    MEYER, T
    MULLER, M
    REGENASS, U
    LYDON, NB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2558 - 2562
  • [37] EPIDERMAL GROWTH-FACTOR REGULATES P21(RAS) THROUGH THE FORMATION OF A COMPLEX OF RECEPTOR, GRB2 ADAPTER PROTEIN, AND SOS NUCLEOTIDE EXCHANGE FACTOR
    BUDAY, L
    DOWNWARD, J
    [J]. CELL, 1993, 73 (03) : 611 - 620
  • [38] Cacace AM, 1999, MOL CELL BIOL, V19, P229
  • [39] Cacace AM, 1996, ONCOGENE, V13, P2517
  • [40] Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase
    Camps, M
    Nichols, A
    Gillieron, C
    Antonsson, B
    Muda, M
    Chabert, C
    Boschert, U
    Arkinstall, S
    [J]. SCIENCE, 1998, 280 (5367) : 1262 - 1265